Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis

Background: Tumour necrosis factor α (TNFα) blockade using infliximab, a chimeric anti-TNFα antibody, is an effective treatment for both psoriasis and psoriatic arthritis (PsA). Objective: To analyse the early effects of infliximab treatment on serial skin and synovial tissue biopsy samples. Methods...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Goedkoop, A, Kraan, M, Teunissen, M, Picavet, D, de Rie, M A, Bos, J, Tak, P
Médium: Artigo
Jazyk:Inglês
Vydáno: 2004
Témata:
Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755073/
https://ncbi.nlm.nih.gov/pubmed/15194570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.018085
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky